胃癌患者术前使用痤疮丙酸杆菌KP - 40进行免疫刺激：一项前瞻性随机研究。
Preoperative immunostimulation with propionibacterium avidum KP-40 in patients with gastric carcinoma: a prospective randomized study.
作者信息
Peters K M, Beuth J, Ko H L, Pulverer G, Kluger J, Grundmann R
机构信息
Orthopädische Klinik, RWTH Aachen.
出版信息
Onkologie. 1990 Apr;13(2):124-7. doi: 10.1159/000216738.
Sixty-eight patients admitted for resection of gastric carcinoma entered a prospectively randomized trial. Patients in the therapy group (n = 34) received a preoperative controlled infusion of 10 mg Propionibacterium avidum KP-40. The therapy and control group did not differ with regard to postoperative complications, tumor recurrence rates (therapy group: 41%, control group: 38%), and patient survival rates (survival rate in the therapy group after 25 months: 53%, in the control group after 25 months: 50%).
68名因胃癌切除术入院的患者进入了一项前瞻性随机试验。治疗组（n = 34）的患者术前接受了10毫克嗜丙酸丙酸杆菌KP - 40的控制性输注。治疗组和对照组在术后并发症、肿瘤复发率（治疗组：41%，对照组：38%）和患者生存率（治疗组25个月后的生存率：53%，对照组25个月后的生存率：50%）方面没有差异。
Zotero 插件